“We spend a lot of time focused on building the experiences that we think are the future of healthcare, and we don’t spend a heck of a lot of time worrying about what other people are doing,” declares Dan Caron, founder and CEO of Health Universe. Here’s a Q&A with the leader of the Kleiner…
Yuzu’s $35 million round was led by General Catalyst and Chemistry, with participation from Anthropic’s Anthology Fund, Bain Future Back Ventures, Timeless Ventures, Lachy Groom and Neo. The post TPA Yuzu Health Aims to Revamp Health Benefits with $35M Boost appeared first on MedCity News.
Soleno Therapeutics brings Neurocrine Biosciences Vykat XR, a drug commercialized for treating the rare genetic disease Prader-Willi syndrome. This blockbuster prospect complements Crenessity, a Neurocrine drug approved for treating a rare endocrine disorder called congenital adrenal hyperplasia. The post Neurocrine’s $2.9B Soleno Buyout Brings What Could Become Its Next Blockbuster Drug appeared first on MedCity…
As commercialization increasingly reflects direct engagement dynamics, differentiation depends less on the volume of data controlled and more on the speed at which systems incorporate feedback. The post From Data Ownership to Learning Velocity in Direct-to-Consumer Healthcare appeared first on MedCity News.
Resource-sharing across large networks of hospitals allows people to receive a higher quality of care across the country, regardless of where they live or how well-resourced their local health system may be. The post Not All Hospitals Have Equal Resources — Knowledge Sharing Can Help Level the Playing Field appeared first on MedCity News.
Startup Pinnacle Medicines is developing peptide drugs with the same efficacy as biologic medicines and the dosing convenience of oral small molecules. The lead program of OrbiMed-incubated Pinnacle is on track to enter the clinic in asthma and chronic obstructive pulmonary disease. The post Pinnacle Medicines Adds $89M for Oral Peptides With Properties of Injectable…
Uma Veerappan of Flare Capital Partners thinks the healthcare AI startups that will come out on top will be companies that integrate seamlessly into workflows, build proprietary datasets and quickly determine how to sell their technology. The post What Will Separate Healthcare AI Winners From Losers? appeared first on MedCity News.
Over the past 15 years, financial and administrative barriers – most notably step therapy mandates and prior authorization requirements – have repeatedly forced patients through suboptimal or ineffective treatments before they can try another therapy, have tied the hands of healthcare professionals and patients alike. Now there’s a possible solution. The post Join the Fight…
A PwC report finds that women’s health is evolving into a much larger, high-growth market as investment expands beyond reproductive care, though it remains underfunded and under-researched. The post The Women’s Health Market Is Poised to Reach $600B by 2030. That’s if ‘We Do Nothing’ appeared first on MedCity News.
An algorithm can flag an irregular heartbeat. But it cannot notice that Tom hasn’t mentioned his late wife in two weeks, or that he’s wearing the same shirt for the fourth day running. Those observations require a person in the room, not a sensor on the wall. The post The Algorithm Won’t Hold Your Mother’s…